Nociceptive behavioural assessments in mouse models of temporomandibular joint disorders

Abstract

Orofacial pain or tenderness is a primary symptom associated with temporomandibular joint (TMJ) disorders (TMDs). To understand the pathological mechanisms underlying TMDs, several mouse models have been developed, including mechanical stimulus-induced TMD and genetic mouse models. However, a lack of feasible approaches for assessing TMD-related nociceptive behaviours in the orofacial region of mice has hindered the in-depth study of TMD-associated mechanisms. This study aimed to explore modifications of three existing methods to analyse nociceptive behaviours using two TMD mouse models: (1) mechanical allodynia was tested using von Frey filaments in the mouse TMJ region by placing mice in specially designed chambers; (2) bite force was measured using the Economical Load and Force (ELF) system; and (3) spontaneous feeding behaviour tests, including eating duration and frequency, were analysed using the Laboratory Animal Behaviour Observation Registration and Analysis System (LABORAS). We successfully assessed changes in nociceptive behaviours in two TMD mouse models, a unilateral anterior crossbite (UAC)-induced TMD mouse model and a β-catenin conditional activation mouse model. We found that the UAC model and β-catenin conditional activation mouse model were significantly associated with signs of increased mechanical allodynia, lower bite force, and decreased spontaneous feeding behaviour, indicating manifestations of TMD. These behavioural changes were consistent with the cartilage degradation phenotype observed in these mouse models. Our studies have shown reliable methods to analyse nociceptive behaviours in mice and may indicate that these methods are valid to assess signs of TMD in mice.

References

[1] Suzuki A, Iwata J. Mouse genetic models for temporomandibular joint development and disorders. Oral. Dis., 2016, 22: 33-38.

[2] Aneiros-Guerrero A, . Genetic polymorphisms in folate pathway enzymes, DRD4 and GSTM1 are related to temporomandibular disorder. BMC Med. Genet., 2011, 12

[3] Ribeiro-Dasilva MC, Fillingim RB, Wallet SM. Estrogen-induced monocytic response correlates with TMD pain: a case control study. J. Dent. Res., 2017, 96: 285-291.

[4] Romero-Reyes M, Uyanik JM. Orofacial pain management: current perspectives. J. Pain. Res., 2014, 7: 99-115.

[5] Dworkin SF, . Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J. Am. Dent. Assoc., 1990, 120: 273-281.

[6] Lyons DN, . Combination drug therapy of pioglitazone and D-cycloserine attenuates chronic orofacial neuropathic pain and anxiety by improving mitochondrial function following trigeminal nerve injury. Clin. J. Pain, 2018, 34: 168-177.

[7] Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol. Behav., 1999, 67: 711-716.

[8] Sugiyo S, Takemura M, Dubner R, Ren K. Trigeminal transition zone/rostral ventromedial medulla connections and facilitation of orofacial hyperalgesia after masseter inflammation in rats. J. Comp. Neurol., 2005, 493: 510-523.

[9] Guo W, . Long lasting pain hypersensitivity following ligation of the tendon of the masseter muscle in rats: a model of myogenic orofacial pain. Mol. Pain, 2010, 6

[10] da Conceição Rivanor RL, . A lectin from the green seaweed Caulerpa cupressoides reduces mechanical hyper-nociception and inflammation in the rat temporomandibular joint during zymosan-induced arthritis. Int. Immunopharmacol., 2014, 21: 34-43.

[11] Alves SM, . Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the zymosan-induced temporomandibular joint inflammatory hypernociception in rats depend on TNF-α inhibition. Pharmacol. Rep., 2017, 69: 764-772.

[12] Denadai-Souza A, . Participation of peripheral tachykinin NK1 receptors in the carrageenan-induced inflammation of the rat temporomandibular joint. Eur. J. Pain., 2009, 13: 812-819.

[13] Chen Y, . Temporomandibular joint pain: a critical role for Trpv4 in the trigeminal ganglion. Pain, 2013, 154: 1295-1304.

[14] Kim SH, . Infliximab partially alleviates the bite force reduction in a mouse model of temporomandibular joint pain. J. Korean Med. Sci., 2015, 30: 552-558.

[15] Kerins CA, Carlson DS, McIntosh JE, Bellinger LL. Meal pattern changes associated with temporomandibular joint inflammation/pain in rats; analgesic effects. Pharmacol. Biochem. Behav., 2003, 75: 181-189.

[16] Harper RP, Brown CM, Triplett MM, Villasenor A, Gatchel RJ. Masticatory function in patients with juvenile rheumatoid arthritis. Pediatr. Dent., 2000, 22: 200-206.

[17] Wu YW, . 17-Beta-estradiol enhanced allodynia of inflammatory temporomandibular joint through upregulation of hippocampal TRPV1 in ovariectomized rats. J. Neurosci., 2010, 30: 8710-8719.

[18] List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia, 2017, 37: 692-704.

[19] Ro JY, Capra N, Masri R. Development of a behavioral assessment of craniofacial muscle pain in lightly anesthetized rats. Pain, 2003, 104: 179-185.

[20] Cao Y, Xie QF, Li K, Light AR, Fu KY. Experimental occlusal interference induces long-term masticatory muscle hyperalgesia in rats. Pain, 2009, 144: 287-293.

[21] Cairns BE, O’Brien M, Dong X-D, Gazerani P. Elevated fractalkine (CX3CL1) levels in the trigeminal ganglion mechanically sensitize temporalis muscle nociceptors. Mol. Neurobiol., 2017, 54: 3695-3706.

[22] Wang S, . Spontaneous and bite-evoked muscle pain are mediated by a common nociceptive pathway with differential contribution by TRPV1. J. Pain, 2017, 18: 1333-1345.

[23] Kleinfelder JW, Ludwigt K. Maximal bite force in patients with reduced periodontal tissue support with and without splinting. J. Periodontol., 2002, 73: 1184-1187.

[24] Yu XM, . Involvement of NMDA receptor mechanisms in jaw electromyographic activity and plasma extravasation induced by inflammatory irritant application to temporomandibular joint region of rats. Pain, 1996, 68: 169-178.

[25] Liu YD, . Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. Osteoarthr. Cartil., 2014, 22: 302-312.

[26] Hui T, . Activation of β-catenin signaling in aggrecan-expressing cells in temporomandibular joint causes osteoarthritis-like defects. Int. J. Oral. Sci., 2018, 10: 13.

[27] Tanaka E, Detamore MS, Mercuri LG. Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J. Dent. Res., 2008, 87: 296-307.

[28] Zhang M, . Unilateral anterior crossbite induces aberrant mineral deposition in degenerative temporomandibular cartilage in rats. Osteoarthr. Cartil., 2016, 24: 921-931.

[29] Xu W, . Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Mol. Pain, 2010, 6

[30] McIlwrath SL, . Inflammatory ‘double hit’ model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice. Eur. J. Pain, 2017, 21: 1209-1223.

[31] Wang GYF, . Sustained and repeated mouth opening leads to development of painful temporomandibular disorders involving macrophage/microglia activation in mice. Pain, 2018, 159: 1277-1288.

[32] Shimizu K, . Microinjection of IL-1β into the trigeminal transition zone produces bilateral NMDA receptor-dependent orofacial hyperalgesia involving descending circuitry. Open Pain. J., 2009, 2: 76-83.

[33] Puri J, . Reduced GABA(A) receptor α6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity. Neuroscience, 2012, 213: 179-190.

[34] Arcan M, Zandman F. A method for in vivo quantitative occlusal strain and stress analysis. J. Biomech., 1984, 17: 67-79.

[35] Harper RP, . Meal pattern analysis in response to temporomandibular joint inflammation in the rat. J. Dent. Res., 2000, 79: 1704-1711.

[36] Williams SH, Peiffer E, Ford S. Gape and bite force in the rodents Onychomys leucogaster and Peromyscus maniculatus: does jaw-muscle anatomy predict performance?. J. Morphol., 2009, 270: 1338-1347.

[37] Dolan JC, Lam DK, Achdjian SH, Schmidt BL. The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain. J. Neurosci. Methods, 2010, 187: 207-215.

[38] Freeman PW, Lemen CA. Measuring bite force in small mammals with a piezo-resistive sensor. J. Mammal., 2008, 89: 513-517.

[39] Kokai S, Yabushita T, Zeredo J, Toda K, Soma K. Functional changes of the temporomandibular joint mechanoreceptors induced by a lateral mandibular shift in rats. Angle Orthod., 2007, 77: 436-441.

[40] Magara J, . Alterations in intermediate filaments expression in disc cells from the rat temporomandibular joint following exposure to continuous compressive force. J. Anat., 2012, 220: 612-621.

[41] Roveroni RC, Parada CA, Cecília M, Veiga FA, Tambeli CH. Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain, 2001, 94: 185-191.

[42] Kramer PR, Kerins CA, Schneiderman E, Bellinger LL. Measuring persistent temporomandibular joint nociception in rats and two mice strains. Physiol. Behav., 2010, 99: 669-678.

[43] Lis K, Grygorowicz T, Cudna A, Szymkowski DE, Bałkowiec-Iskra E. Inhibition of TNF reduces mechanical orofacial hyperalgesia induced by complete freund’s adjuvant by a TRPV1-dependent mechanism in mice. Pharmacol. Rep., 2017, 69: 1380-1385.

[44] Wang Z, . Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint. J. Biol. Chem., 2018, 293: 8761-8774.

[45] Li X, . The effects of tamoxifen on mouse behavior. Genes Brain Behav., 2020, 19

[46] Berger M, . Association between estrogen levels and temporomandibular disorders: a systematic literature review. Prz. Menopauzalny, 2015, 14: 260-270.

[47] LeResche L. Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit. Rev. Oral. Biol. Med., 1997, 8: 291-305.

[48] Fávaro-Moreira NC, Okoti LW, Furini R, Tambeli CH. Gonadal hormones modulate the responsiveness to local β-blocker-induced antinociception in the temporomandibular joint of male and female rats. Eur. J. Pain, 2015, 19: 772-780.

[49] Liao L, . Deletion of Runx2 in condylar chondrocytes disrupts TMJ tissue homeostasis. J. Cell. Physiol., 2019, 234: 3436-3444.

[50] Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cartil., 2010, 18: S17-S23.

[51] Shen J, . Deletion of the transforming growth factor β receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum., 2013, 65: 3107-3119.

[52] Jiao K, . Subchondral bone loss following orthodontically induced cartilage degradation in the mandibular condyles of rats. Bone, 2011, 48: 362-371.

[53] Lu L, . Changes of temporomandibular joint and semaphorin 4D/Plexin-B1 expression in a mouse model of incisor malocclusion. J. Oral. Facial Pain Headache, 2014, 28: 68-79.

[54] Miao X, . Upregulation of cystathionine-β-synthetase expression contributes to inflammatory pain in rat temporomandibular joint. Mol. Pain, 2014, 10: 9-9.

[55] Durham ZL, Hawkins JL, Durham PL. Tumor necrosis factor-Alpha stimulates cytokine expression and transient sensitization of trigeminal nociceptive neurons. Arch. Oral. Biol., 2017, 75: 100-106.

[56] Quinn LP, . Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. J. Neurosci. Methods, 2006, 156: 218-227.

[57] Van de Weerd HA, . Validation of a new system for the automatic registration of behaviour in mice and rats. Behav. Process., 2001, 53: 11-20.

Funding

Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)(R01AR070222, R03AG061460)